NAM DONG WOO, MD

Name: DONGWOO NAM

Address : Department of Acupuncture & moxibustion, Korean Medicine Hospital, Kyung Hee Medical Center, 1 Hoegi-dong, Dongdaemun-gu, Seoul, Korea

e-mail : 

Nationality : Republic of Korea

Education: 

1998.03-2004.02

Korea   Kyung Hee University

Oriental Medicine 

Bachelor

2004.03-2007.02 

Korea   Kyung Hee University

Oriental Medicine (Acupuncture & Moxibustion)

M.S.

2007.03-2010.02 

Korea   Kyung Hee University 

Oriental Medicine (Acupuncture & Moxibustion)

Ph.D.

Work Experience

2004.03.01-2005.02.28 (1yr)

Oriental Medicine Hospital, Kyung Hee Medical Center

Intern

2005.03.01-2008.02.28 (3yrs)

Oriental Medicine Hospital, Kyung Hee Medical Center

Resident

2008.03.01-2009.02.28 (1yr)

Kyung Hee University, Cancer Preventive Material Development Research Center (CPMDRC)

Researcher

2009.03.01-2011.02.28(3yrs)

Oriental Medicine Hospital, Kyung Hee Medical Center

Fellow

2009.03.01-현재

East-West Medicine Research Center, Kyung Hee Medical Center

Researcher

2010.07.01-2011.02.28 (8 months)

Kyung Hee University, Oriental Medicine Clinic in Baku, Azeribaijan

Fellow

2011.03.01-2013.02 (2yrs)

Department of Acupuncture & Moxibustion, Oriental Medicine College, Kyung Hee University

Full time lecturer

2013.03.01-2017.02

Department of Acupuncture & Moxibustion, Oriental Medicine College, Kyung Hee University

Assistant professor

2017.0301-present

Department of Acupuncture & Moxibustion, Oriental Medicine College, Kyung Hee University

Associate professor

Major research interests:

Clinical Oriental Medicine, Acupuncture & Moxibustion, Spine and Joint disorders, Cancer

Professional memberships:

Director of General Affairs and International Affairs – Society of Korean Oriental Medicine

Director of International Affairs – Korean Acupuncture & Moxibustion Medicine Society

Director of General Affairs – Korean Medicine Spine & Joint Society

Director of Research and Development – Spinal Manipulation Society

Recent Studies

Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways

International Immunopharmacology      2011 

Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4

Immunopharmacol Immunotoxicol.2012

A Hexane Fraction of Guava Leaves (Psidium guajava L.) Induces Anticancer Activity by Suppressing AKT/Mammalian Target of Rapamycin/Ribosomal p70 S6 Kinase in Human Prostate Cancer Cells  

J Med Food      2012    SCI

Antiproliferative Effects of Dangyuja (Citrus grandis Osbeck) Leaves Through Suppression of Constitutive Signal Transducer and Activator of Transcription 3 Activation in Human Prostate Carcinoma DU145 Cells 

J Med Food      2012    SCI

The Butanol Fraction of Guava (Psidium cattleianum Sabine) Leaf Extract Suppresses MMP-2 and MMP-9 Expression and Activity Through the Suppression of the ERK1/2 MAPK Signaling Pathway 

Nutr Cancer.    2012    SCI

Melittin Suppresses VEGF-A-Induced Tumor Growth by Blocking VEGFR-2 and the COX-2-Mediated MAPK Signaling Pathway   

J Nat Prod        2013    SCI

Indirubin, a purple 3,2-bisindole, inhibited allergic contact dermatitis via regulating T helper (Th)-mediated immune system in DNCB-induced model 

J Ethnopharmacol        2013    SCI

Study to Establish Ojeok-san (Five Accumulation Powder: Wu Ji San) Administration Criteria and a Questionnaire to Evaluate the Holistic Effects of Ojeok-San on patients with low back pain 

J Altern Complement Med       2013    SCI

​

Brassinin Induces Apoptosis in PC-3 Human Prostate Cancer Cells through the Suppression of PI3K/Akt/mTOR/S6K1 Signaling Cascades 

Phytotherapy Research 2013    SCI

β-Caryophyllene oxide potentiates TNFα-induced apoptosis and inhibits invasion through down-modulation of NF-κB-regulated gene products 

Apoptosis         2014    SCI

Anti-Metastatic Effect of Supercritical Extracts from the Citrus hassaku Pericarp via Inhibition of C-X-C Chemokine Receptor Type 4 (CXCR4) and Matrix Metalloproteinase-9 (MMP-9)

Phytotherapy Research2014    SCI

8-hydrocalamenene, derived from Reynoutria elliptica, suppresses constitutive STAT3 activation, inhibiting proliferation and enhancing chemosensitization of human multiple myeloma cells

J Med Food      2014    SCI